Guj. Themis Bio.

58
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE942C01045
  • NSEID: GUJTHEM
  • BSEID: 506879
INR
408.55
18.85 (4.84%)
BSENSE

Dec 19

BSE+NSE Vol: 8.71 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -11.20% vs 14.45% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -11.60% vs 6.93% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 58.81% vs 30.08% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -17.56% vs 2.06% in Mar 2024

Compare Profit and Loss Results of Guj. Themis Bio.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
150.00
257.00
-107.00
-41.63%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
150.00
257.00
-107.00
-41.63%
Expenditure (Ex Depriciation)
Stock Adjustments
-1.00
-16.00
15.00
93.75%
Raw Materials Consumed
25.00
171.00
-146.00
-85.38%
Power & Fuel Cost
26.00
0.00
26.00
0%
Employee Cost
11.00
31.00
-20.00
-64.52%
Operating Expenses
8.00
4.00
4.00
100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
15.00
-15.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
4.00
0.00
4.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
81.00
245.00
-164.00
-66.94%
Operating Profit (PBDIT) excl Other Income
69.00
11.00
58.00
527.27%
Other Income
1.00
4.00
-3.00
-75.00%
Operating Profit (PBDIT)
71.00
16.00
55.00
343.75%
Interest
0.00
1.00
-1.00
-100.00%
Profit before Depriciation and Tax
70.00
15.00
55.00
366.67%
Depreciation
5.00
3.00
2.00
66.67%
Profit Before Taxation & Exceptional Items
65.00
11.00
54.00
490.91%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
65.00
11.00
54.00
490.91%
Provision for Tax
16.00
3.00
13.00
433.33%
Profit After Tax
48.00
8.00
40.00
500.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
191.00
30.00
161.00
536.67%
Profit Available for appropriations
240.00
38.00
202.00
531.58%
Appropriations
240.00
38.00
202.00
531.58%
Equity Dividend (%)
67%
10%
57.00
Earnings Per Share
4.48
3.16
1.32
41.77%
Profit And Loss - Net Sales
Net Sales 150.80 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -11.20% vs 14.45% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 69.60 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -11.60% vs 6.93% in Mar 2024

Profit And Loss - Interest
Interest 0.36 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 58.81% vs 30.08% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 48.77 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -17.56% vs 2.06% in Mar 2024